Today: 25 June 2026
Browse Category

Stock Market 30 January 2026

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog shares jumped 6.4% to $306.57 after the company posted record quarterly sales of $1.1 billion and raised its 2026 outlook. Bookings reached $2.3 billion, pushing backlog up 30% to $3.3 billion. The company lifted its quarterly dividend 3% to $0.30 per share. Free cash flow turned negative as Moog increased inventory and faced tariff pressures on margins.
AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile stock drops nearly 9% as Vanguard stake filing hits tape; traders eye late-February launch

AST SpaceMobile shares fell 8.7% to $111.50 Friday, swinging from a session high of $129.74 to a low of $109.04 on heavy volume. Vanguard disclosed a 7.68% stake in the company as of Dec. 31 in a regulatory filing. Investors are watching for the planned late-February BlueBird 7 satellite launch aboard Blue Origin’s New Glenn-3 rocket.
Abbott stock rebounds as Exact Sciences vote nears after broker upgrade

Abbott stock rebounds as Exact Sciences vote nears after broker upgrade

Abbott Laboratories shares rose 2.6% to $108.89 Friday after missing revenue targets and guiding first-quarter adjusted EPS below analyst estimates. Freedom Capital Markets upgraded the stock to “buy” but cut its price target. Abbott expects to close its $23 billion Exact Sciences acquisition by Q2 2026. Exact Sciences shareholders will vote on the merger Feb. 20.
Citigroup stock edges up as Trump taps Warsh for Fed, inflation data tests rate bets

Citigroup stock edges up as Trump taps Warsh for Fed, inflation data tests rate bets

Citigroup shares rose 0.4% to $115.65 Friday, outperforming a broader U.S. stock decline as investors eyed a midnight federal funding deadline and awaited next week’s jobs report. The move followed Donald Trump’s nomination of Kevin Warsh for Fed chair and a surprise jump in producer prices. Most major bank stocks were little changed. The Fed left rates steady this week at 3.50%-3.75%.
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
TTM Technologies stock price rises as $200 million Raytheon contract keeps buyers interested

TTM Technologies stock price rises as $200 million Raytheon contract keeps buyers interested

TTM Technologies shares rose 2.6% to $98.98 Friday after landing a supply contract with Raytheon worth up to $200 million over three years. The deal covers hardware for Raytheon’s air and missile defense radar program. TTM will join the S&P MidCap 400, replacing Civitas Resources, which could spur index-driven buying. Jabil and Sanmina shares fell, while Plexus edged higher.
SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi Technologies shares fell 8% to $22.48 Friday after volatile trading, as investors reacted to strong Q4 profits and raised 2026 forecasts. The company reported record loan originations of $10.5 billion and a 78% jump in financial services income. SoFi now expects 2026 adjusted net revenue of $4.655 billion and adjusted EBITDA near $1.6 billion. Next earnings report is set for April 28.
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria shares rose 3.1% to $61.61 Friday, rebounding after Thursday’s earnings report sent the stock lower. The company named CFO Salvatore Mancuso as incoming CEO, effective May 14, and is expanding exports to tap a federal excise-tax rebate. Altria’s Q4 net revenue fell 2.1% to $5.846 billion, with adjusted EPS at $1.30. Market share for its on! pouches dropped to 13% as competition from Philip Morris’s Zyn intensified.
30 January 2026
Charter Communications stock jumps as broadband losses come in lighter than feared

Charter Communications stock jumps as broadband losses come in lighter than feared

Charter Communications shares rose 8% to $206.76 after reporting a smaller-than-expected loss of 119,000 internet customers in Q4, beating analyst forecasts. Revenue fell 2% to $13.6 billion, missing estimates, while mobile line additions of 428,000 lagged expectations. Net income dropped to $1.3 billion. The company plans $11.4 billion in capital spending for 2026 amid ongoing competition and industry pressures.
30 January 2026
Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Joby Aviation shares fell 4.8% to $10.61 Friday after the company priced a $1.2 billion stock and convertible note offering at $11.35 per share, about 15% below the Jan. 28 close. The deal includes 52.86 million shares and $600 million in 0.75% convertible notes due 2032. Settlement is expected Monday, with underwriters holding options to increase both offerings. Rival eVTOL stocks also declined.
30 January 2026
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific shares rose 1.7% to $93.87 Friday afternoon, outpacing a broader market decline. The move comes ahead of the company’s Feb. 4 earnings report and conference call, its first since announcing a $14.5 billion deal to acquire Penumbra. Investors are watching for details on the acquisition’s impact and the 2026 outlook.
Modine stock jumps after $1 billion Gentherm deal accelerates pivot to data-center cooling

Modine stock jumps after $1 billion Gentherm deal accelerates pivot to data-center cooling

Modine shares rose 5.8% to $187.00 Friday after announcing it will spin off its Performance Technologies unit and merge it with Gentherm in a $1 billion tax-free deal. Modine shareholders will receive about 21 million Gentherm shares valued near $790 million and a $210 million cash payout. The deal requires Gentherm shareholder and regulatory approval. Modine’s quarterly results are due Feb. 4 after market close.
30 January 2026
Southwest Airlines stock slips as LUV cools off after 18.7% surge on profit forecast

Southwest Airlines stock slips as LUV cools off after 18.7% surge on profit forecast

Southwest Airlines shares fell 1.1% to $47.99 Friday afternoon, pulling back after Thursday’s 18.7% surge on a profit outlook upgrade and new fee-based strategy. BMO Capital raised its rating to “outperform” and lifted the price target to $57.50. The airline now expects adjusted EPS of at least $4.00 for 2026. Investors remain cautious as Southwest shifts away from its traditional no-fee model.
30 January 2026
Workday stock bounces as software selloff cools, but AI worries still hang over WDAY

Workday stock bounces as software selloff cools, but AI worries still hang over WDAY

Workday shares rose 0.7% to $175.87 Friday afternoon after swinging between $172.80 and $176.64. The move followed a sector-wide selloff triggered by SAP, ServiceNow, and Microsoft on Thursday. Investors are awaiting Workday’s earnings report, due around Feb. 24, for updates on subscription growth and margins. Software stocks remain volatile as the market weighs AI’s impact and cost pressures.

Stock Market Today

  • Temple & Webster Shares Jump 5.59% on ASX Amid Controlled Trading
    June 25, 2026, 11:24 AM EDT. Temple & Webster Group Ltd (ASX:TPW) shares rose 5.59% to AUD 6.04, within an intraday range of AUD 5.76 to AUD 6.07, signaling positive market sentiment. Despite a trading volume of 936,738 shares below the average 1.34 million, the stock showed balanced buying and selling interest on the ASX. The company's market capitalisation stands near AUD 666.64 million. TPW operates in the online homewares and furniture retail segment, sensitive to consumer discretionary trends and housing demand cycles. The 52-week price fluctuated significantly between AUD 4.53 and AUD 29.06, highlighting volatility over the past year. The session's narrow price range suggested a consolidation phase following prior price moves, with cautious market participation.

Latest News

US stocks now: Broad gains balance $416 billion drop in megacap tech

US stocks now: Broad gains balance $416 billion drop in megacap tech

25 June 2026
Apple, Nvidia, Microsoft, Alphabet, and Meta lost about $416 billion in combined market value as investors rotated into Dow and small-cap stocks, with Apple dragging after raising MacBook and iPad prices due to higher memory costs; meanwhile, Micron surged 10.4% on strong earnings and guidance, and Qualcomm gained 3.6% after boosting long-term revenue targets.
Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

25 June 2026
Bio-Techne surged 19% to $70.17 after Merck KGaA’s $73 per share cash offer, leaving a $2.83 spread as the deal awaits shareholder and regulatory approval, with closing expected in late 2026 or early 2027; trading volume soared past short interest, and the deal values Bio-Techne at $11.3 billion, less than 9.4 times fiscal 2025 sales.
Go toTop